Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06339658
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-03-25
Brief Title:
ICG vs Blue Patent as a Tracer in the Performance of TAD in Patients With cN1 Breast Carcinoma After Neoadjuvant Chemotherapy
Sponsor:
Hospital Universitari de Bellvitge
Organization:
Hospital Universitari de Bellvitge
Organization Data
Organization:
Hospital Universitari de Bellvitge
Class:
OTHER
Study ID:
TAD-ICG
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hospital Universitari de Bellvitge
Lead Sponsor Class:
OTHER
Responsible Party:
Amparo Garcia-Tejedor
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hospital Universitari de Bellvitge
Old Name:
None
Old Organization:
None